Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q23929261
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000024.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q23929261
|
024
|
|
|
‡a
0000-0002-6621-9350
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q23929261
|
043
|
|
|
‡c
DE
|
046
|
|
|
‡f
19600000
|
100
|
0 |
|
‡a
Stephan Becker
‡c
chercheur
‡9
fr
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Stephan Becker
‡c
German virologist
‡9
en
|
400
|
0 |
|
‡a
Stephan Becker
‡c
viroloog
‡9
nl
|
400
|
0 |
|
‡a
Stephan Becker
‡c
deutscher Virologe
‡9
de
|
400
|
0 |
|
‡a
Stephan Becker
‡c
forskare
‡9
sv
|
400
|
0 |
|
‡a
Stephan Becker
‡c
virólogo alemán
‡9
es
|
670
|
|
|
‡a
Author's 131 Replication and assembly of filoviruses.
|
670
|
|
|
‡a
Author's A Fluorescently Labeled Marburg Virus Glycoprotein as a New Tool to Study Viral Transport and Assembly
|
670
|
|
|
‡a
Author's A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
|
670
|
|
|
‡a
Author's A live-cell imaging system for visualizing the transport of Marburg virus nucleocapsid-like structures
|
670
|
|
|
‡a
Author's A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
|
670
|
|
|
‡a
Author's A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry.
|
670
|
|
|
‡a
Author's A Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein (EBOV GP) Nanoparticle Vaccine with Matrix-M™ Adjuvant in Healthy Adults
|
670
|
|
|
‡a
Author's A Single Amino Acid Change in the Marburg Virus Matrix Protein VP40 Provides a Replicative Advantage in a Species-Specific Manner
|
670
|
|
|
‡a
Author's Acute Ebola virus disease patient treatment and health-related quality of life in health care professionals: A controlled study
|
670
|
|
|
‡a
Author's Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity
|
670
|
|
|
‡a
Author's An active site mutation increases the polymerase activity of the guinea pig-lethal Marburg virus
|
670
|
|
|
‡a
Author's An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
|
670
|
|
|
‡a
Author's Analysis of determinants in filovirus glycoproteins required for tetherin antagonism
|
670
|
|
|
‡a
Author's Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015
|
670
|
|
|
‡a
Author's Analysis of Ebola Virus Entry Into Macrophages
|
670
|
|
|
‡a
Author's Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR.
|
670
|
|
|
‡a
Author's Analysis of the multifunctionality of Marburg virus VP40
|
670
|
|
|
‡a
Author's Assembly of the Marburg virus envelope
|
670
|
|
|
‡a
Author's Basolateral budding of Marburg virus: VP40 retargets viral glycoprotein GP to the basolateral surface
|
670
|
|
|
‡a
Author's Bile salt-induced apoptosis involves NADPH oxidase isoform activation
|
670
|
|
|
‡a
Author's Budding of Marburgvirus is associated with filopodia
|
670
|
|
|
‡a
Author's Can falls be predicted with gait analytical and posturographic measurement systems? A prospective follow-up study in a nursing home population
|
670
|
|
|
‡a
Author's CD95 tyrosine phosphorylation is required for CD95 oligomerization
|
670
|
|
|
‡a
Author's Characterization of severe acute respiratory syndrome coronavirus membrane protein
|
670
|
|
|
‡a
Author's Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry Factors
|
670
|
|
|
‡a
Author's Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP).
|
670
|
|
|
‡a
Author's Cleavage of the Junin virus nucleoprotein serves a decoy function to inhibit the induction of apoptosis during infection
|
670
|
|
|
‡a
Author's Complete Genome Sequence of an Ebola Virus Isolate Imported from Sierra Leone to Germany Determined by Circle Sequencing
|
670
|
|
|
‡a
Author's Comprehensive Characterization of Cellular Immune Responses Following Ebola Virus Infection.
|
670
|
|
|
‡a
Author's Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016.
|
670
|
|
|
‡a
Author's Corrigendum: Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells
|
670
|
|
|
‡a
Author's Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells
|
670
|
|
|
‡a
Author's Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
|
670
|
|
|
‡a
Author's Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association
|
670
|
|
|
‡a
Author's DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus
|
670
|
|
|
‡a
Author's Detectable Vesicular Stomatitis Virus
|
670
|
|
|
‡a
Author's Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans
|
670
|
|
|
‡a
Author's Development and characterization of an indirect ELISA to detect SARS-CoV - 2 spike protein-specific antibodies
|
670
|
|
|
‡a
Author's Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus
|
670
|
|
|
‡a
Author's Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus
|
670
|
|
|
‡a
Author's Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection
|
670
|
|
|
‡a
Author's Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories
|
670
|
|
|
‡a
Author's Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells
|
670
|
|
|
‡a
Author's Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
|
670
|
|
|
‡a
Author's Dynamic phosphorylation of Ebola virus VP30 in NP-induced inclusion bodies
|
670
|
|
|
‡a
Author's Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle
|
670
|
|
|
‡a
Author's Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers
|
670
|
|
|
‡a
Author's Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis
|
670
|
|
|
‡a
Author's Ebola Virus Nucleocapsid-Like Structures Utilize Arp2/3 Signaling for Intracellular Long-Distance Transport
|
670
|
|
|
‡a
Author's Ebola virus proteins NP, VP35, and VP24 are essential and sufficient to mediate nucleocapsid transport
|
670
|
|
|
‡a
Author's Ebola virus transcription activator VP30 is a zinc-binding protein
|
670
|
|
|
‡a
Author's Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation
|
670
|
|
|
‡a
Author's Ectodomain shedding of the glycoprotein GP of Ebola virus
|
670
|
|
|
‡a
Author's Efficient budding of the tacaribe virus matrix protein z requires the nucleoprotein
|
670
|
|
|
‡a
Author's Electron tomography reveals the steps in filovirus budding
|
670
|
|
|
‡a
Author's Endosomal Acidification and Activation of NADPH Oxidase Isoforms Are Upstream Events in Hyperosmolarity-induced Hepatocyte Apoptosis
|
670
|
|
|
‡a
Author's Epidemiological study to detect active SARS-CoV-2 infections and seropositive persons in a selected cohort of employees in the Frankfurt am Main metropolitan area
|
670
|
|
|
‡a
Author's Epitopes of Naturally Acquired and Vaccine-induced Anti-Ebola Virus Glycoprotein Antibodies in Single Amino Acid Resolution
|
670
|
|
|
‡a
Author's Establishment and application of an infectious virus-like particle system for Marburg virus
|
670
|
|
|
‡a
Author's Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection
|
670
|
|
|
‡a
Author's Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens
|
670
|
|
|
‡a
Author's External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014 - 2016 Ebola outbreak in West Africa
|
670
|
|
|
‡a
Author's Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever
|
670
|
|
|
‡a
Author's Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency
|
670
|
|
|
‡a
Author's Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names
|
670
|
|
|
‡a
Author's First international quality assurance study on the rapid detection of viral agents of bioterrorism
|
670
|
|
|
‡a
Author's Fluorescence resonance energy transfer analysis of proapoptotic CD95-EGF receptor interactions in Huh7 cells.
|
670
|
|
|
‡a
Author's [Four years after the Ebola crisis: Challenges, experiences, and implications in the German public health context]
|
670
|
|
|
‡a
Author's From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein
|
670
|
|
|
‡a
Author's Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak.
|
670
|
|
|
‡a
Author's Generation of therapeutic antisera for emerging viral infections
|
670
|
|
|
‡a
Author's Genome Sequence of Lassa Virus Isolated from the First Domestically Acquired Case in Germany
|
670
|
|
|
‡a
Author's Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles
|
670
|
|
|
‡a
Author's Hemorrhagic Diathesis in Borrelia recurrentis Infection Imported to Germany
|
670
|
|
|
‡a
Author's Hexamer phasing governs transcription initiation in the 3'-leader of Ebola virus
|
670
|
|
|
‡a
Author's High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus
|
670
|
|
|
‡a
Author's Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription
|
670
|
|
|
‡a
Author's Hospital hygiene - Influenza
|
670
|
|
|
‡a
Author's Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus
|
670
|
|
|
‡a
Author's Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea
|
670
|
|
|
‡a
Author's Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation
|
670
|
|
|
‡a
Author's Hydrophobic bile salts trigger ceramide formation through endosomal acidification
|
670
|
|
|
‡a
Author's Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices
|
670
|
|
|
‡a
Author's In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics
|
670
|
|
|
‡a
Author's Inclusion bodies are a site of ebolavirus replication
|
670
|
|
|
‡a
Author's Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.
|
670
|
|
|
‡a
Author's Influenza virus budding from the tips of cellular microvilli in differentiated human airway epithelial cells
|
670
|
|
|
‡a
Author's Inhibition of filovirus replication by the zinc finger antiviral protein
|
670
|
|
|
‡a
Author's Inhibition of Marburg virus protein expression and viral release by RNA interference
|
670
|
|
|
‡a
Author's Interaction with Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells
|
670
|
|
|
‡a
Author's Intraobserver reliability of posturography in healthy subjects
|
670
|
|
|
‡a
Author's Intraobserver reliability of posturography in patients with vestibular neuritis
|
670
|
|
|
‡a
Author's Investigating the zoonotic origin of the West African Ebola epidemic
|
670
|
|
|
‡a
Author's Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis
|
670
|
|
|
‡a
Author's Involvement of the Src family kinase yes in bile salt-induced apoptosis
|
670
|
|
|
‡a
Author's Live-Cell Imaging of Filoviruses
|
670
|
|
|
‡a
Author's Live-cell imaging of Marburg virus-infected cells uncovers actin-dependent transport of nucleocapsids over long distances
|
670
|
|
|
‡a
Author's Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
|
670
|
|
|
‡a
Author's Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
|
670
|
|
|
‡a
Author's LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus
|
670
|
|
|
‡a
Author's Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany
|
670
|
|
|
‡a
Author's Management of Microbiological Samples in a Confirmed Case of Ebola Virus Disease: Constraints and Limitations.
|
670
|
|
|
‡a
Author's Marburg biosafety and biosecurity scale (MBBS): a framework for risk assessment and risk communication
|
670
|
|
|
‡a
Author's Marburg virus inclusions: A virus-induced microcompartment and interface to multivesicular bodies and the late endosomal compartment
|
670
|
|
|
‡a
Author's Marburg virus regulates the IRE1/XBP1-dependent unfolded protein response to ensure efficient viral replication
|
670
|
|
|
‡a
Author's Measles virus M protein-driven particle production does not involve the endosomal sorting complex required for transport
|
670
|
|
|
‡a
Author's Measles virus M protein-driven particle production does not involve the endosomal sorting complex required for transport (ESCRT) system
|
670
|
|
|
‡a
Author's Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies
|
670
|
|
|
‡a
Author's Morphology of Marburg virus NP-RNA.
|
670
|
|
|
‡a
Author's Multi-level inhibition of coronavirus replication by chemical ER stress
|
670
|
|
|
‡a
Author's Multivesicular bodies as a platform for formation of the Marburg virus envelope
|
670
|
|
|
‡a
Author's New Lineage of Lassa Virus, Togo, 2016
|
670
|
|
|
‡a
Author's Nipah Virus Matrix Protein Influences Fusogenicity and Is Essential for Particle Infectivity and Stability
|
670
|
|
|
‡a
Author's Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors
|
670
|
|
|
‡a
Author's Nucleocapsid formation and RNA synthesis of Marburg virus is dependent on two coiled coil motifs in the nucleoprotein
|
670
|
|
|
‡a
Author's Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide
|
670
|
|
|
‡a
Author's Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
|
670
|
|
|
‡a
Author's Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication
|
670
|
|
|
‡a
Author's Phosphorylation of Marburg virus matrix protein VP40 triggers assembly of nucleocapsids with the viral envelope at the plasma membrane
|
670
|
|
|
‡a
Author's Phosphorylation of Marburg virus NP region II modulates viral RNA synthesis
|
670
|
|
|
‡a
Author's Phosphorylation of VP30 impairs ebola virus transcription
|
670
|
|
|
‡a
Author's Phylogeny of the SARS coronavirus.
|
670
|
|
|
‡a
Author's Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
|
670
|
|
|
‡a
Author's Post-exposure prophylaxis with rVSV-ZEBOV following exposure to a patient with Ebola virus disease relapse in the UK: an operational, safety and immunogenicity report
|
670
|
|
|
‡a
Author's Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus
|
670
|
|
|
‡a
Author's Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu).
|
670
|
|
|
‡a
Author's Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay.
|
670
|
|
|
‡a
Author's Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations
|
670
|
|
|
‡a
Author's Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
|
670
|
|
|
‡a
Author's Regulation of VP30-Dependent Transcription by RNA Sequence and Structure in the Genomic Ebola Virus Promoter
|
670
|
|
|
‡a
Author's Risk communication and crisis communication in infectious disease outbreaks in Germany: what is being done, and what needs to be done
|
670
|
|
|
‡a
Author's RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription
|
670
|
|
|
‡a
Author's RNA binding specificity of Ebola virus transcription factor VP30
|
670
|
|
|
‡a
Author's RNA secondary structure at the transcription start site influences EBOV transcription initiation and replication in a length- and stability-dependent manner
|
670
|
|
|
‡a
Author's Role of Ebola virus VP30 in transcription reinitiation.
|
670
|
|
|
‡a
Author's Role of the transmembrane domain of marburg virus surface protein GP in assembly of the viral envelope
|
670
|
|
|
‡a
Author's Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
|
670
|
|
|
‡a
Author's Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial
|
670
|
|
|
‡a
Author's SARS--beginning to understand a new virus
|
670
|
|
|
‡a
Author's SARS vaccine protective in mice
|
670
|
|
|
‡a
Author's Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription
|
670
|
|
|
‡a
Author's Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care
|
670
|
|
|
‡a
Author's Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography
|
670
|
|
|
‡a
Author's Structural insight into Marburg virus nucleoprotein-RNA complex formation
|
670
|
|
|
‡a
Author's Structure and assembly of the Ebola virus nucleocapsid
|
670
|
|
|
‡a
Author's Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein
|
670
|
|
|
‡a
Author's Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry
|
670
|
|
|
‡a
Author's Synthetic generation of influenza vaccine viruses for rapid response to pandemics
|
670
|
|
|
‡a
Author's Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV.
|
670
|
|
|
‡a
Author's Tacaribe virus but not junin virus infection induces cytokine release from primary human monocytes and macrophages
|
670
|
|
|
‡a
Author's Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa
|
670
|
|
|
‡a
Author's Tetherin inhibits Nipah virus but not Ebola virus replication in fruit bat cells
|
670
|
|
|
‡a
Author's The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
|
670
|
|
|
‡a
Author's The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection
|
670
|
|
|
‡a
Author's The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
|
670
|
|
|
‡a
Author's The Ebola Virus Nucleoprotein Recruits the Host PP2A-B56 Phosphatase to Activate Transcriptional Support Activity of VP30.
|
670
|
|
|
‡a
Author's The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
|
670
|
|
|
‡a
Author's The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation
|
670
|
|
|
‡a
Author's The integrity of the YxxL motif of Ebola virus VP24 is important for the transport of nucleocapsid-like structures and for the regulation of viral RNA synthesis
|
670
|
|
|
‡a
Author's The Marburg virus surface protein GP is phosphorylated at its ectodomain
|
670
|
|
|
‡a
Author's The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway
|
670
|
|
|
‡a
Author's The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties
|
670
|
|
|
‡a
Author's The molecular tweezer CLR01 inhibits Ebola and Zika virus infection
|
670
|
|
|
‡a
Author's The natural compound silvestrol is a potent inhibitor of Ebola virus replication
|
670
|
|
|
‡a
Author's The New World arenavirus Tacaribe virus induces caspase-dependent apoptosis in infected cells.
|
670
|
|
|
‡a
Author's The Src family kinase Yes triggers hyperosmotic activation of the epidermal growth factor receptor and CD95.
|
670
|
|
|
‡a
Author's TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets
|
670
|
|
|
‡a
Author's Transport of Ebolavirus Nucleocapsids Is Dependent on Actin Polymerization: Live-Cell Imaging Analysis of Ebolavirus-Infected Cells
|
670
|
|
|
‡a
Author's Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles
|
670
|
|
|
‡a
Author's VACCINES. Ebola virus vaccines--preparing for the unexpected
|
670
|
|
|
‡a
Author's Vacuolar protein sorting pathway contributes to the release of Marburg virus
|
670
|
|
|
‡a
Author's Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses
|
670
|
|
|
‡a
Author's Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA
|
670
|
|
|
‡a
Author's Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae
|
670
|
|
|
‡a
Author's Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae
|
670
|
|
|
‡a
Author's VP24 of Marburg virus influences formation of infectious particles
|
670
|
|
|
‡a
Author's VP40 octamers are essential for Ebola virus replication.
|
670
|
|
|
‡a
Author's VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/DNB|1206855991
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/8982158551019016540003
|
670
|
|
|
‡a
wikidata site links
‡u
https://de.wikipedia.org/wiki/Stephan_Becker_(Virologe)
|
909
|
|
|
‡a
(orcid) 0000000266219350
‡9
1
|
912
|
|
|
‡a
temporalandspatialanalysisofthe20142015ebolavirusoutbreakinwestafrica
‡A
Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa
‡9
1
|
912
|
|
|
‡a
filovirusrefseqentriesevaluationandselectionoffilovirustypevariantstypesequencesandnames
‡A
Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names
‡9
1
|
919
|
|
|
‡a
tacaribevirusbutnotjuninvirusinfectioninducescytokinereleasefromprimaryhumanmonocytesandmacrophages
‡A
Tacaribe virus but not junin virus infection induces cytokine release from primary human monocytes and macrophages
‡9
1
|
919
|
|
|
‡a
syntheticgenerationofinfluenzavaccinevirusesforrapidresponsetopandemics
‡A
Synthetic generation of influenza vaccine viruses for rapid response to pandemics
‡9
1
|
919
|
|
|
‡a
studiesonmembranetopologynglycosylationandfunctionalityofsarscovmembraneprotein
‡A
Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein
‡9
1
|
919
|
|
|
‡a
structuralinsightintomarburgvirusnucleoproteinrnacomplexformation
‡A
Structural insight into Marburg virus nucleoprotein-RNA complex formation
‡9
1
|
919
|
|
|
‡a
basolateralbuddingofmarburgvirusvp40retargetsviralglycoproteingptothebasolateralsurface
‡A
Basolateral budding of Marburg virus: VP40 retargets viral glycoprotein GP to the basolateral surface
‡9
1
|
919
|
|
|
‡a
safetyandimmunogenicityofamodifiedvacciniavirusankaravectorvaccinecandidateformiddleeastrespiratorysyndromeanopenlabelphase1trial
‡A
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial
‡9
1
|
919
|
|
|
‡a
sarsbeginningtounderstandanewvirus
‡A
SARS--beginning to understand a new virus
‡9
1
|
919
|
|
|
‡a
assemblyofthemarburgvirusenvelope
‡A
Assembly of the Marburg virus envelope
‡9
1
|
919
|
|
|
‡a
rnasecondarystructureatthetranscriptionstartsiteinfluencesebovtranscriptioninitiationandreplicationinalengthandstabilitydependentmanner
‡A
RNA secondary structure at the transcription start site influences EBOV transcription initiation and replication in a length- and stability-dependent manner
‡9
1
|
919
|
|
|
‡a
rnabindingspecificityofebolavirustranscriptionfactorvp30
‡A
RNA binding specificity of Ebola virus transcription factor VP30
‡9
1
|
919
|
|
|
‡a
profileandpersistenceofthevirusspecificneutralizinghumoralimmuneresponseinhumansurvivorsofsudanebolavirusgulu
‡A
Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu).
‡9
1
|
919
|
|
|
‡a
managementofaccidentalexposuretoebolavirusinthebiosafetylevel4laboratoryhamburggermany
‡A
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany
‡9
1
|
919
|
|
|
‡a
marburgbiosafetyandbiosecurityscalembbsaframeworkforriskassessmentandriskcommunication
‡A
Marburg biosafety and biosecurity scale (MBBS): a framework for risk assessment and risk communication
‡9
1
|
919
|
|
|
‡a
measlesvirus1000proteindrivenparticleproductiondoesnotinvolvetheendosomalsortingcomplexrequiredfortransportescrtsystem
‡A
Measles virus M protein-driven particle production does not involve the endosomal sorting complex required for transport (ESCRT) system
‡9
1
|
919
|
|
|
‡a
fluorescentlylabeledmarburgvirusglycoproteinasanewtooltostudyviraltransportandassembly
‡A
A Fluorescently Labeled Marburg Virus Glycoprotein as a New Tool to Study Viral Transport and Assembly
‡9
1
|
919
|
|
|
‡a
analysisoftheinteractionofebolavirusglycoproteinwith600signdendriticcellspecificintercellularadhesionmolecule3grabbingnonintegrinanditshomologue600signr
‡A
Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR.
‡9
1
|
919
|
|
|
‡a
131replicationandassemblyoffiloviruses
‡A
131 Replication and assembly of filoviruses.
‡9
1
|
919
|
|
|
‡a
roleofebolavirusvp30intranscriptionreinitiation
‡A
Role of Ebola virus VP30 in transcription reinitiation.
‡9
1
|
919
|
|
|
‡a
roleofthetransmembranedomainofmarburgvirussurfaceproteingpinassemblyoftheviralenvelope
‡A
Role of the transmembrane domain of marburg virus surface protein GP in assembly of the viral envelope
‡9
1
|
919
|
|
|
‡a
safetyandimmunogenicityofrvsvδgzebovgpebolavaccineinadultsandchildreninlambarenegabonaphase1randomisedtrial
‡A
Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial
‡9
1
|
919
|
|
|
‡a
bilesaltinducedapoptosisinvolvesnadphoxidaseisoformactivation
‡A
Bile salt-induced apoptosis involves NADPH oxidase isoform activation
‡9
1
|
919
|
|
|
‡a
marburgvirusregulatestheire1xbp1dependentunfoldedproteinresponsetoensureefficientviralreplication
‡A
Marburg virus regulates the IRE1/XBP1-dependent unfolded protein response to ensure efficient viral replication
‡9
1
|
919
|
|
|
‡a
structuraldissectionofebolavirusanditsassemblydeterminantsusingcryoelectrontomography
‡A
Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography
‡9
1
|
919
|
|
|
‡a
structureandassemblyoftheebolavirusnucleocapsid
‡A
Structure and assembly of the Ebola virus nucleocapsid
‡9
1
|
919
|
|
|
‡a
characterizationofthefilovirusresistantcelllineshsy5yrevealsredundantroleofcellsurfaceentryfactors
‡A
Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry Factors
‡9
1
|
919
|
|
|
‡a
livecellimagingofmarburgvirusinfectedcellsuncoversactindependenttransportofnucleocapsidsoverlongdistances
‡A
Live-cell imaging of Marburg virus-infected cells uncovers actin-dependent transport of nucleocapsids over long distances
‡9
1
|
919
|
|
|
‡a
analysisofdeterminantsinfilovirusglycoproteinsrequiredfortetherinantagonism
‡A
Analysis of determinants in filovirus glycoproteins required for tetherin antagonism
‡9
1
|
919
|
|
|
‡a
phosphorylationofvp30impairsebolavirustranscription
‡A
Phosphorylation of VP30 impairs ebola virus transcription
‡9
1
|
919
|
|
|
‡a
middleeastrespiratorysyndromecoronavirusspikeproteindeliveredbymodifiedvacciniavirusankaraefficientlyinducesvirusneutralizingantibodies
‡A
Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies
‡9
1
|
919
|
|
|
‡a
acuteebolavirusdiseasepatienttreatmentandhealthrelatedqualityoflifeinhealthcareprofessionalsacontrolledstudy
‡A
Acute Ebola virus disease patient treatment and health-related quality of life in health care professionals: A controlled study
‡9
1
|
919
|
|
|
‡a
randomizedblindeddoserangingtrialofanebolavirusglycoproteinebovgpnanoparticlevaccinewithmatrixmtmadjuvantinhealthyadults
‡A
A Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein (EBOV GP) Nanoparticle Vaccine with Matrix-M™ Adjuvant in Healthy Adults
‡9
1
|
919
|
|
|
‡a
phase1trialsofrvsvebolavaccineinafricaandeurope
‡A
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
‡9
1
|
919
|
|
|
‡a
oligomerizationofebolavirusvp30isessentialforviraltranscriptionandcanbeinhibitedbyasyntheticpeptide
‡A
Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide
‡9
1
|
919
|
|
|
‡a
nipahvirusmatrixproteininfluencesfusogenicityandisessentialforparticleinfectivityandstability
‡A
Nipah Virus Matrix Protein Influences Fusogenicity and Is Essential for Particle Infectivity and Stability
‡9
1
|
919
|
|
|
‡a
singleaminoacidchangeinthemarburgvirusmatrixproteinvp40providesareplicativeadvantageinaspeciesspecificmanner
‡A
A Single Amino Acid Change in the Marburg Virus Matrix Protein VP40 Provides a Replicative Advantage in a Species-Specific Manner
‡9
1
|
919
|
|
|
‡a
adjuvantformulatedviruslikeparticlesexpressingnativelikeformsofthelassavirusenvelopesurfaceglycoproteinareimmunogenicandinduceantibodieswithbroadlyneutralizingactivity
‡A
Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity
‡9
1
|
919
|
|
|
‡a
polymorphismwithintheinternalfusionloopoftheebolavirusglycoproteinmodulateshostcellentry
‡A
A Polymorphism within the Internal Fusion Loop of the Ebola Virus Glycoprotein Modulates Host Cell Entry.
‡9
1
|
919
|
|
|
‡a
efficientmethodtomakehumanmonoclonalantibodiesfrommemorybcellspotentneutralizationofsarscoronavirus
‡A
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
‡9
1
|
919
|
|
|
‡a
activesitemutationincreasesthepolymeraseactivityoftheguineapiglethalmarburgvirus
‡A
An active site mutation increases the polymerase activity of the guinea pig-lethal Marburg virus
‡9
1
|
919
|
|
|
‡a
monovalentchimpanzeeadenovirusebolavaccineboostedwithmva
‡A
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
‡9
1
|
919
|
|
|
‡a
measlesvirus1000proteindrivenparticleproductiondoesnotinvolvetheendosomalsortingcomplexrequiredfortransport
‡A
Measles virus M protein-driven particle production does not involve the endosomal sorting complex required for transport
‡9
1
|
919
|
|
|
‡a
phylogenyofthesarscoronavirus
‡A
Phylogeny of the SARS coronavirus.
‡9
1
|
919
|
|
|
‡a
livecellimagingsystemforvisualizingthetransportofmarburgvirusnucleocapsidlikestructures
‡A
A live-cell imaging system for visualizing the transport of Marburg virus nucleocapsid-like structures
‡9
1
|
919
|
|
|
‡a
managementofmicrobiologicalsamplesinaconfirmedcaseofebolavirusdiseaseconstraintsandlimitations
‡A
Management of Microbiological Samples in a Confirmed Case of Ebola Virus Disease: Constraints and Limitations.
‡9
1
|
919
|
|
|
‡a
rnabindingofebolavirusvp30isessentialforactivatingviraltranscription
‡A
RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription
‡9
1
|
919
|
|
|
‡a
marburgvirusinclusionsavirusinducedmicrocompartmentandinterfacetomultivesicularbodiesandthelateendosomalcompartment
‡A
Marburg virus inclusions: A virus-induced microcompartment and interface to multivesicular bodies and the late endosomal compartment
‡9
1
|
919
|
|
|
‡a
analysisofebolavirusentryintomacrophages
‡A
Analysis of Ebola Virus Entry Into Macrophages
‡9
1
|
919
|
|
|
‡a
intraobserverreliabilityofposturographyinpatientswithvestibularneuritis
‡A
Intraobserver reliability of posturography in patients with vestibular neuritis
‡9
1
|
919
|
|
|
‡a
analysisofthemultifunctionalityofmarburgvirusvp40
‡A
Analysis of the multifunctionality of Marburg virus VP40
‡9
1
|
919
|
|
|
‡a
livecellimagingoffiloviruses
‡A
Live-Cell Imaging of Filoviruses
‡9
1
|
919
|
|
|
‡a
involvementofthesrcfamilykinaseyesinbilesaltinducedapoptosis
‡A
Involvement of the Src family kinase yes in bile salt-induced apoptosis
‡9
1
|
919
|
|
|
‡a
involvementofnadphoxidaseisoformsandsrcfamilykinasesincd95dependenthepatocyteapoptosis
‡A
Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis
‡9
1
|
919
|
|
|
‡a
investigatingthezoonoticoriginofthewestafricanebolaepidemic
‡A
Investigating the zoonotic origin of the West African Ebola epidemic
‡9
1
|
919
|
|
|
‡a
intraobserverreliabilityofposturographyinhealthysubjects
‡A
Intraobserver reliability of posturography in healthy subjects
‡9
1
|
919
|
|
|
‡a
interactionwithtsg101isnecessaryfortheefficienttransportandreleaseofnucleocapsidsinmarburgvirusinfectedcells
‡A
Interaction with Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells
‡9
1
|
919
|
|
|
‡a
inhibitionofmarburgvirusproteinexpressionandviralreleasebyrnainterference
‡A
Inhibition of Marburg virus protein expression and viral release by RNA interference
‡9
1
|
919
|
|
|
‡a
inhibitionoffilovirusreplicationbythezincfingerantiviralprotein
‡A
Inhibition of filovirus replication by the zinc finger antiviral protein
‡9
1
|
919
|
|
|
‡a
infectionofnaivetargetcellswithviruslikeparticlesimplicationsforthefunctionofebolavirusvp24
‡A
Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.
‡9
1
|
919
|
|
|
‡a
invitroevaluationofantisensernaefficacyagainstfilovirusinfectionbyuseofreversegenetics
‡A
In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics
‡9
1
|
919
|
|
|
‡a
hypoosmoticswellingandammoniaincreaseoxidativestressbynadphoxidaseinculturedastrocytesandvitalbrainslices
‡A
Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices
‡9
1
|
919
|
|
|
‡a
hydrophobicbilesaltstriggerceramideformationthroughendosomalacidification
‡A
Hydrophobic bile salts trigger ceramide formation through endosomal acidification
‡9
1
|
919
|
|
|
‡a
humoralandcellularimmuneresponseinducedbyrvsvδgzebovgpvaccineamongfrontlineworkersduringthe20132016westafricaebolaoutbreakinguinea
‡A
Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea
‡9
1
|
919
|
|
|
‡a
hydrophobicbilesaltsinducehepatocyteshrinkagevianadphoxidaseactivation
‡A
Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation
‡9
1
|
919
|
|
|
‡a
humancelltropismandinnateimmunesysteminteractionsofhumanrespiratorycoronavirusemccomparedtothoseofsevereacuterespiratorysyndromecoronavirus
‡A
Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus
‡9
1
|
919
|
|
|
‡a
homooligomerizationofmarburgvirusvp35isessentialforitsfunctioninreplicationandtranscription
‡A
Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription
‡9
1
|
919
|
|
|
‡a
highsecretionofinterferonsbyhumanplasmacytoiddendriticcellsuponrecognitionofmiddleeastrespiratorysyndromecoronavirus
‡A
High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus
‡9
1
|
919
|
|
|
‡a
hexamerphasinggovernstranscriptioninitiationinthe3leaderofebolavirus
‡A
Hexamer phasing governs transcription initiation in the 3'-leader of Ebola virus
‡9
1
|
919
|
|
|
‡a
hospitalhygieneinfluenza
‡A
Hospital hygiene - Influenza
‡9
1
|
919
|
|
|
‡a
genusspecificrecruitmentoffilovirusribonucleoproteincomplexesintobuddingparticles
‡A
Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles
‡9
1
|
919
|
|
|
‡a
generationoftherapeuticantiseraforemergingviralinfections
‡A
Generation of therapeutic antisera for emerging viral infections
‡9
1
|
919
|
|
|
‡a
functionalcharacterizationofadaptivemutationsduringthewestafricanebolavirusoutbreak
‡A
Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak.
‡9
1
|
919
|
|
|
‡a
genomesequenceoflassavirusisolatedfromthe1domesticallyacquiredcaseingermany
‡A
Genome Sequence of Lassa Virus Isolated from the First Domestically Acquired Case in Germany
‡9
1
|
919
|
|
|
‡a
fromhybridomastoarobustmicroalgalbasedproductionplatformmoleculardesignofadiatomsecretingmonoclonalantibodiesdirectedagainstthemarburgvirusnucleoprotein
‡A
From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein
‡9
1
|
919
|
|
|
‡a
fluorescenceresonanceenergytransferanalysisofproapoptoticcd95egfreceptorinteractionsinhuh7cells
‡A
Fluorescence resonance energy transfer analysis of proapoptotic CD95-EGF receptor interactions in Huh7 cells.
‡9
1
|
919
|
|
|
‡a
1internationalqualityassurancestudyontherapiddetectionofviralagentsofbioterrorism
‡A
First international quality assurance study on the rapid detection of viral agents of bioterrorism
‡9
1
|
919
|
|
|
‡a
4yearsaftertheebolacrisischallengesexperiencesandimplicationsinthegermanpublichealthcontext
‡A
[Four years after the Ebola crisis: Challenges, experiences, and implications in the German public health context]
‡9
1
|
919
|
|
|
‡a
inclusionbodiesareasiteofebolavirusreplication
‡A
Inclusion bodies are a site of ebolavirus replication
‡9
1
|
919
|
|
|
‡a
fieldevaluationofcapillarybloodsamplesasacollectionspecimenfortherapiddiagnosisofebolavirusinfectionduringanoutbreakemergency
‡A
Field Evaluation of Capillary Blood Samples as a Collection Specimen for the Rapid Diagnosis of Ebola Virus Infection During an Outbreak Emergency
‡9
1
|
919
|
|
|
‡a
externalqualityassessmentstudyforebolaviruspcrdiagnosticpromotesinternationalpreparednessduringthe20142016ebolaoutbreakinwestafrica
‡A
External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014 - 2016 Ebola outbreak in West Africa
‡9
1
|
919
|
|
|
‡a
exploringsynergiesbetweenacademiaandvaccinemanufacturersapilotstudyonhowtorapidlyproducevaccinestocombatemergingpathogens
‡A
Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens
‡9
1
|
919
|
|
|
‡a
hemorrhagicdiathesisinborreliarecurrentisinfectionimportedtogermany
‡A
Hemorrhagic Diathesis in Borrelia recurrentis Infection Imported to Germany
‡9
1
|
919
|
|
|
‡a
establishmentoffruitbatcellsrousettusaegyptiacusasamodelsystemfortheinvestigationoffiloviralinfection
‡A
Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection
‡9
1
|
919
|
|
|
‡a
favipiravirandribavirintreatmentofepidemiologicallylinkedcasesoflassafever
‡A
Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever
‡9
1
|
919
|
|
|
‡a
establishmentandapplicationofaninfectiousviruslikeparticlesystemformarburgvirus
‡A
Establishment and application of an infectious virus-like particle system for Marburg virus
‡9
1
|
919
|
|
|
‡a
influenzavirusbuddingfromthetipsofcellularmicrovilliindifferentiatedhumanairwayepithelialcells
‡A
Influenza virus budding from the tips of cellular microvilli in differentiated human airway epithelial cells
‡9
1
|
919
|
|
|
‡a
epitopesofnaturallyacquiredandvaccineinducedantiebolavirusglycoproteinantibodiesinsingleaminoacidresolution
‡A
Epitopes of Naturally Acquired and Vaccine-induced Anti-Ebola Virus Glycoprotein Antibodies in Single Amino Acid Resolution
‡9
1
|
919
|
|
|
‡a
ebolavirusproteinsnpvp35andvp24areessentialandsufficienttomediatenucleocapsidtransport
‡A
Ebola virus proteins NP, VP35, and VP24 are essential and sufficient to mediate nucleocapsid transport
‡9
1
|
919
|
|
|
‡a
endosomalacidificationandactivationofnadphoxidaseisoformsareupstreameventsinhyperosmolarityinducedhepatocyteapoptosis
‡A
Endosomal Acidification and Activation of NADPH Oxidase Isoforms Are Upstream Events in Hyperosmolarity-induced Hepatocyte Apoptosis
‡9
1
|
919
|
|
|
‡a
electrontomographyrevealsthestepsinfilovirusbudding
‡A
Electron tomography reveals the steps in filovirus budding
‡9
1
|
919
|
|
|
‡a
epidemiologicalstudytodetectactivesarscov2infectionsandseropositivepersonsinaselectedcohortofemployeesinthefrankfurtammainmetropolitanarea
‡A
Epidemiological study to detect active SARS-CoV-2 infections and seropositive persons in a selected cohort of employees in the Frankfurt am Main metropolitan area
‡9
1
|
919
|
|
|
‡a
efficientbuddingofthetacaribevirusmatrixproteinzrequiresthenucleoprotein
‡A
Efficient budding of the tacaribe virus matrix protein z requires the nucleoprotein
‡9
1
|
919
|
|
|
‡a
ebolavirusvp30mediatedtranscriptionisregulatedbyrnasecondarystructureformation
‡A
Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation
‡9
1
|
919
|
|
|
‡a
ebolavirustranscriptionactivatorvp30isazincbindingprotein
‡A
Ebola virus transcription activator VP30 is a zinc-binding protein
‡9
1
|
919
|
|
|
‡a
ectodomainsheddingoftheglycoproteingpofebolavirus
‡A
Ectodomain shedding of the glycoprotein GP of Ebola virus
‡9
1
|
919
|
|
|
‡a
ebolavirusentershostcellsbymacropinocytosisandclathrinmediatedendocytosis
‡A
Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis
‡9
1
|
919
|
|
|
‡a
polyclonalandconvergentantibodyresponsetoebolavirusvaccinervsvzebov
‡A
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
‡9
1
|
919
|
|
|
‡a
ebolavirusnucleocapsidlikestructuresutilizearp23signalingforintracellularlongdistancetransport
‡A
Ebola Virus Nucleocapsid-Like Structures Utilize Arp2/3 Signaling for Intracellular Long-Distance Transport
‡9
1
|
919
|
|
|
‡a
ebolaandmarburgvirusmatrixlayersarelocallyorderedassembliesofvp40dimers
‡A
Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers
‡9
1
|
919
|
|
|
‡a
dynamicphosphorylationofvp30isessentialforebolaviruslifecycle
‡A
Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle
‡9
1
|
919
|
|
|
‡a
protectiveefficacyofrecombinantmodifiedvacciniavirusankaradeliveringmiddleeastrespiratorysyndromecoronavirusspikeglycoprotein
‡A
Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein
‡9
1
|
919
|
|
|
‡a
postexposureprophylaxiswithrvsvzebovfollowingexposuretoapatientwithebolavirusdiseaserelapseintheukanoperationalsafetyandimmunogenicityreport
‡A
Post-exposure prophylaxis with rVSV-ZEBOV following exposure to a patient with Ebola virus disease relapse in the UK: an operational, safety and immunogenicity report
‡9
1
|
919
|
|
|
‡a
dynamicphosphorylationofebolavirusvp30innpinducedinclusionbodies
‡A
Dynamic phosphorylation of Ebola virus VP30 in NP-induced inclusion bodies
‡9
1
|
919
|
|
|
‡a
regulationofvp30dependenttranscriptionbyrnasequenceandstructureinthegenomicebolaviruspromoter
‡A
Regulation of VP30-Dependent Transcription by RNA Sequence and Structure in the Genomic Ebola Virus Promoter
‡9
1
|
919
|
|
|
‡a
profilingthenativespecifichumanhumoralimmuneresponsetosudanebolavirusstraingulubychemiluminescenceenzymelinkedimmunosorbentassay
‡A
Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent assay.
‡9
1
|
919
|
|
|
‡a
analysisofdiagnosticfindingsfromtheeuropeanmobilelaboratoryingueckedouguineamarch2014throughmarch
‡A
Analysis of Diagnostic Findings From the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015
‡9
1
|
919
|
|
|
‡a
dosedependenttcelldynamicsandcytokinecascadefollowingrvsvzebovimmunization
‡A
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization
‡9
1
|
919
|
|
|
‡a
differentialtranscriptionalresponsestoebolaandmarburgvirusinfectioninbatandhumancells
‡A
Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells
‡9
1
|
919
|
|
|
‡a
developmentofanimmunofiltrationbasedantigendetectionassayforrapiddiagnosisofebolavirusinfection
‡A
Development of an immunofiltration-based antigen-detection assay for rapid diagnosis of Ebola virus infection
‡9
1
|
919
|
|
|
‡a
nucleicacidsensingtolllikereceptorsareessentialforthecontrolofendogenousretrovirusviremiaandervinducedtumors
‡A
Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors
‡9
1
|
919
|
|
|
‡a
developmentofanantibodycaptureelisausinginactivatedebolazairemakonavirus
‡A
Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus
‡9
1
|
919
|
|
|
‡a
morphologyofmarburgvirusnprna
‡A
Morphology of Marburg virus NP-RNA.
‡9
1
|
919
|
|
|
‡a
newlineageoflassavirustogo
‡A
New Lineage of Lassa Virus, Togo, 2016
‡9
1
|
919
|
|
|
‡a
multilevelinhibitionofcoronavirusreplicationbychemicalerstress
‡A
Multi-level inhibition of coronavirus replication by chemical ER stress
‡9
1
|
919
|
|
|
‡a
diagnosticreversetranscriptionpolymerasechainreactionkitforfilovirusesbasedonthestraincollectionsofalleuropeanbiosafetylevel4laboratories
‡A
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories
‡9
1
|
919
|
|
|
‡a
nucleocapsidformationandrnasynthesisofmarburgvirusisdependenton2coiledcoilmotifsinthenucleoprotein
‡A
Nucleocapsid formation and RNA synthesis of Marburg virus is dependent on two coiled coil motifs in the nucleoprotein
‡9
1
|
919
|
|
|
‡a
multivesicularbodiesasaplatformforformationofthemarburgvirusenvelope
‡A
Multivesicular bodies as a platform for formation of the Marburg virus envelope
‡9
1
|
919
|
|
|
‡a
phosphorylationofebolavirusvp30influencesthecompositionoftheviralnucleocapsidcompleximpactonviraltranscriptionandreplication
‡A
Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication
‡9
1
|
919
|
|
|
‡a
phosphorylationofmarburgvirusnpregion2modulatesviralrnasynthesis
‡A
Phosphorylation of Marburg virus NP region II modulates viral RNA synthesis
‡9
1
|
919
|
|
|
‡a
phosphorylationofmarburgvirusmatrixproteinvp40triggersassemblyofnucleocapsidswiththeviralenvelopeattheplasmamembrane
‡A
Phosphorylation of Marburg virus matrix protein VP40 triggers assembly of nucleocapsids with the viral envelope at the plasma membrane
‡9
1
|
919
|
|
|
‡a
vp40thematrixproteinofmarburgvirusisassociatedwithmembranesofthelateendosomalcompartment
‡A
VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment
‡9
1
|
919
|
|
|
‡a
developmentandcharacterizationofanindirectelisatodetectsarscov2spikeproteinspecificantibodies
‡A
Development and characterization of an indirect ELISA to detect SARS-CoV - 2 spike protein-specific antibodies
‡9
1
|
919
|
|
|
‡a
vp40octamersareessentialforebolavirusreplication
‡A
VP40 octamers are essential for Ebola virus replication.
‡9
1
|
919
|
|
|
‡a
productionofmonoclonalantibodiesanddevelopmentofanantigencaptureelisadirectedagainsttheenvelopeglycoproteingpofebolavirus
‡A
Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus
‡9
1
|
919
|
|
|
‡a
virusnomenclaturebelowthespecieslevelastandardizednomenclaturefornaturalvariantsofvirusesassignedtothefamilyfiloviridae
‡A
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae
‡9
1
|
919
|
|
|
‡a
highlyimmunogenicandprotectivemiddleeastrespiratorysyndromecoronavirusvaccinebasedonarecombinantmeaslesvirusvaccineplatform
‡A
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
‡9
1
|
919
|
|
|
‡a
virusnomenclaturebelowthespecieslevelastandardizednomenclatureforfilovirusstrainsandvariantsrescuedfromcdna
‡A
Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA
‡9
1
|
919
|
|
|
‡a
proposalforarevisedtaxonomyofthefamilyfiloviridaeclassificationnamesoftaxaandvirusesandvirusabbreviations
‡A
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations
‡9
1
|
919
|
|
|
‡a
detectablevesicularstomatitisvirusvsvspecifichumoralandcellularimmuneresponsesfollowingvsvebolavirusvaccinationinhumans
‡A
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans
‡9
1
|
919
|
|
|
‡a
riskcommunicationandcrisiscommunicationininfectiousdiseaseoutbreaksingermanywhatisbeingdoneandwhatneedstobedone
‡A
Risk communication and crisis communication in infectious disease outbreaks in Germany: what is being done, and what needs to be done
‡9
1
|
919
|
|
|
‡a
lsectininteractswithfilovirusglycoproteinsandthespikeproteinofsarscoronavirus
‡A
LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus
‡9
1
|
919
|
|
|
‡a
longitudinalisolationofpotentneargermlinesarscov2neutralizingantibodiesfromcovid19patients
‡A
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
‡9
1
|
919
|
|
|
‡a
buddingofmarburgvirusisassociatedwithfilopodia
‡A
Budding of Marburgvirus is associated with filopodia
‡9
1
|
919
|
|
|
‡a
severeebolavirusdiseasewithvascularleakageandmultiorganfailuretreatmentofapatientinintensivecare
‡A
Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care
‡9
1
|
919
|
|
|
‡a
longitudinalantibodyandtcellresponsesinebolavirusdiseasesurvivorsandcontactsanobservationalcohortstudy
‡A
Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study
‡9
1
|
919
|
|
|
‡a
detectablevesicularstomatitisvirus
‡A
Detectable Vesicular Stomatitis Virus
‡9
1
|
919
|
|
|
‡a
crystalstructureofthe100terminaldomainofebolavirusvp30revealsaroleintranscriptionandnucleocapsidassociation
‡A
Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association
‡9
1
|
919
|
|
|
‡a
serinearginineproteinkinase1regulatesebolavirustranscription
‡A
Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription
‡9
1
|
919
|
|
|
‡a
sarsvaccineprotectiveinmice
‡A
SARS vaccine protective in mice
‡9
1
|
919
|
|
|
‡a
vaccinesebolavirusvaccinespreparingfortheunexpected
‡A
VACCINES. Ebola virus vaccines--preparing for the unexpected
‡9
1
|
919
|
|
|
‡a
tsg101isrecruitedbyalatedomainofthenucleocapsidproteintosupportbuddingofmarburgviruslikeparticles
‡A
Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles
‡9
1
|
919
|
|
|
‡a
600signand600signrinteractwiththeglycoproteinofmarburgvirusandthesproteinofsevereacuterespiratorysyndromecoronavirus
‡A
DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus
‡9
1
|
919
|
|
|
‡a
canfallsbepredictedwithgaitanalyticalandposturographicmeasurementsystemsaprospectivefollowupstudyinanursinghomepopulation
‡A
Can falls be predicted with gait analytical and posturographic measurement systems? A prospective follow-up study in a nursing home population
‡9
1
|
919
|
|
|
‡a
tmprss2andfurinarebothessentialforproteolyticactivationandspreadofsarscov2inhumanairwayepithelialcellsandprovidepromisingdrugtargets
‡A
TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets
‡9
1
|
919
|
|
|
‡a
cd95tyrosinephosphorylationisrequiredforcd95oligomerization
‡A
CD95 tyrosine phosphorylation is required for CD95 oligomerization
‡9
1
|
919
|
|
|
‡a
suraminisapotentinhibitorofchikungunyaandebolaviruscellentry
‡A
Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry
‡9
1
|
919
|
|
|
‡a
characterizationofsevereacuterespiratorysyndromecoronavirusmembraneprotein
‡A
Characterization of severe acute respiratory syndrome coronavirus membrane protein
‡9
1
|
919
|
|
|
‡a
systemsvaccinologyidentifiesanearlyinnateimmunesignatureasacorrelateofantibodyresponsestotheebolavaccinervsvzebov
‡A
Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV.
‡9
1
|
919
|
|
|
‡a
tetherininhibitsnipahvirusbutnotebolavirusreplicationinfruitbatcells
‡A
Tetherin inhibits Nipah virus but not Ebola virus replication in fruit bat cells
‡9
1
|
919
|
|
|
‡a
newworldarenavirustacaribevirusinducescaspasedependentapoptosisininfectedcells
‡A
The New World arenavirus Tacaribe virus induces caspase-dependent apoptosis in infected cells.
‡9
1
|
919
|
|
|
‡a
characterizationofthelassavirusmatrixproteinzelectronmicroscopicstudyofviruslikeparticlesandinteractionwiththenucleoproteinnp
‡A
Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP).
‡9
1
|
919
|
|
|
‡a
crystalstructureofsarscov2mainproteaseprovidesabasisfordesignofimprovedαketoamideinhibitors
‡A
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
‡9
1
|
919
|
|
|
‡a
cryoelectrontomographyofmarburgvirusparticlesandtheirmorphogenesiswithininfectedcells
‡A
Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells
‡9
1
|
919
|
|
|
‡a
corrigendumdifferentialtranscriptionalresponsestoebolaandmarburgvirusinfectioninbatandhumancells
‡A
Corrigendum: Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells
‡9
1
|
919
|
|
|
‡a
controlmeasuresfollowingacaseofimportedlassafeverfromtogonorthrhinewestphaliagermany
‡A
Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016.
‡9
1
|
919
|
|
|
‡a
matrixproteinofmarburgvirusistransportedtotheplasmamembranealongcellularmembranesexploitingtheretrogradelateendosomalpathway
‡A
The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway
‡9
1
|
919
|
|
|
‡a
marburgvirussurfaceproteingpisphosphorylatedatitsectodomain
‡A
The Marburg virus surface protein GP is phosphorylated at its ectodomain
‡9
1
|
919
|
|
|
‡a
integrityoftheyxxlmotifofebolavirusvp24isimportantforthetransportofnucleocapsidlikestructuresandfortheregulationofviralrnasynthesis
‡A
The integrity of the YxxL motif of Ebola virus VP24 is important for the transport of nucleocapsid-like structures and for the regulation of viral RNA synthesis
‡9
1
|
919
|
|
|
‡a
importanceofthenpvp35ratioinebolavirusnucleocapsidformation
‡A
The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation
‡9
1
|
919
|
|
|
‡a
effectofdoseonthesafetyandimmunogenicityofthevsvebolacandidatevaccinearandomiseddoubleblindplacebocontrolledphase12trial
‡A
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
‡9
1
|
919
|
|
|
‡a
matrixproteinvp40fromebolavirusoctamerizesintoporelikestructureswithspecificrnabindingproperties
‡A
The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties
‡9
1
|
919
|
|
|
‡a
moleculartweezerclr01inhibitsebolaandzikavirusinfection
‡A
The molecular tweezer CLR01 inhibits Ebola and Zika virus infection
‡9
1
|
919
|
|
|
‡a
naturalcompoundsilvestrolisapotentinhibitorofebolavirusreplication
‡A
The natural compound silvestrol is a potent inhibitor of Ebola virus replication
‡9
1
|
919
|
|
|
‡a
srcfamilykinaseyestriggershyperosmoticactivationoftheepidermalgrowthfactorreceptorandcd95
‡A
The Src family kinase Yes triggers hyperosmotic activation of the epidermal growth factor receptor and CD95.
‡9
1
|
919
|
|
|
‡a
completegenomesequenceofanebolavirusisolateimportedfromsierraleonetogermanydeterminedbycirclesequencing
‡A
Complete Genome Sequence of an Ebola Virus Isolate Imported from Sierra Leone to Germany Determined by Circle Sequencing
‡9
1
|
919
|
|
|
‡a
transportofebolavirusnucleocapsidsisdependentonactinpolymerizationlivecellimaginganalysisofebolavirusinfectedcells
‡A
Transport of Ebolavirus Nucleocapsids Is Dependent on Actin Polymerization: Live-Cell Imaging Analysis of Ebolavirus-Infected Cells
‡9
1
|
919
|
|
|
‡a
ebolavirusglycoproteincontributestobutisnotsufficientforvirulenceinvivo
‡A
The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo
‡9
1
|
919
|
|
|
‡a
comprehensivecharacterizationofcellularimmuneresponsesfollowingebolavirusinfection
‡A
Comprehensive Characterization of Cellular Immune Responses Following Ebola Virus Infection.
‡9
1
|
919
|
|
|
‡a
vacuolarproteinsortingpathwaycontributestothereleaseofmarburgvirus
‡A
Vacuolar protein sorting pathway contributes to the release of Marburg virus
‡9
1
|
919
|
|
|
‡a
virucidalactivityofworldhealthorganizationrecommendedformulationsagainstenvelopedvirusesincludingzikaebolaandemergingcoronaviruses
‡A
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging Coronaviruses
‡9
1
|
919
|
|
|
‡a
cytoplasmicdomainofmarburgvirusgpmodulatesearlystepsofviralinfection
‡A
The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection
‡9
1
|
919
|
|
|
‡a
virusnomenclaturebelowthespecieslevelastandardizednomenclatureforlaboratoryanimaladaptedstrainsandvariantsofvirusesassignedtothefamilyfiloviridae
‡A
Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae
‡9
1
|
919
|
|
|
‡a
cleavageofthejuninvirusnucleoproteinservesadecoyfunctiontoinhibittheinductionofapoptosisduringinfection
‡A
Cleavage of the Junin virus nucleoprotein serves a decoy function to inhibit the induction of apoptosis during infection
‡9
1
|
919
|
|
|
‡a
vp24ofmarburgvirusinfluencesformationofinfectiousparticles
‡A
VP24 of Marburg virus influences formation of infectious particles
‡9
1
|
919
|
|
|
‡a
clinicallyapproveddrugsamiodaronedronedaroneandverapamilinhibitfiloviruscellentry
‡A
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
‡9
1
|
919
|
|
|
‡a
ebolavirusnucleoproteinrecruitsthehostpp2ab56phosphatasetoactivatetranscriptionalsupportactivityofvp30
‡A
The Ebola Virus Nucleoprotein Recruits the Host PP2A-B56 Phosphatase to Activate Transcriptional Support Activity of VP30.
‡9
1
|
919
|
|
|
‡a
developmentcharacterizationanduseofmonoclonalvp40antibodiesforthedetectionofebolavirus
‡A
Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus
‡9
1
|
943
|
|
|
‡a
201x
‡A
2015
‡9
3
|
946
|
|
|
‡a
b
‡9
1
|
947
|
|
|
‡a
DE
‡9
1
|
996
|
|
|
‡2
LC|no 99081312
|
996
|
|
|
‡2
DNB|1041915047
|
996
|
|
|
‡2
LC|n 85819408
|
996
|
|
|
‡2
SIMACOB|327337315
|
996
|
|
|
‡2
ISNI|0000000021273463
|
996
|
|
|
‡2
PTBNP|279415
|
996
|
|
|
‡2
SUDOC|086018450
|
996
|
|
|
‡2
DNB|1038610311
|
996
|
|
|
‡2
NUKAT|n 2002036038
|
996
|
|
|
‡2
RERO|A003624583
|
996
|
|
|
‡2
SUDOC|236088149
|
996
|
|
|
‡2
DNB|114581249X
|
996
|
|
|
‡2
DNB|1015467334
|
996
|
|
|
‡2
DNB|143607960
|
996
|
|
|
‡2
DNB|1128826194
|
996
|
|
|
‡2
RERO|A002983121
|
996
|
|
|
‡2
RERO|A002983123
|
996
|
|
|
‡2
RERO|A002983124
|
996
|
|
|
‡2
ISNI|0000000046214275
|
996
|
|
|
‡2
DNB|113703243X
|
996
|
|
|
‡2
NSK|000502751
|
996
|
|
|
‡2
DBC|87097919316920
|
996
|
|
|
‡2
DNB|1216456178
|
996
|
|
|
‡2
ISNI|0000000423304031
|
996
|
|
|
‡2
DNB|13923330X
|
996
|
|
|
‡2
CAOONL|ncf13692979
|
996
|
|
|
‡2
RERO|A017240081
|
996
|
|
|
‡2
ISNI|0000000110557871
|
996
|
|
|
‡2
SUDOC|157894037
|
996
|
|
|
‡2
DNB|1077200536
|
996
|
|
|
‡2
RERO|A006413748
|
996
|
|
|
‡2
DNB|1097213528
|
996
|
|
|
‡2
ISNI|0000000354228265
|
996
|
|
|
‡2
LC|n 2011041773
|
996
|
|
|
‡2
LC|nr 00018420
|
996
|
|
|
‡2
DE633|pe30020920
|
996
|
|
|
‡2
DNB|1077200854
|
996
|
|
|
‡2
NTA|073781983
|
996
|
|
|
‡2
LC|n 2021184126
|
996
|
|
|
‡2
ISNI|0000000392273083
|
996
|
|
|
‡2
LC|n 80039811
|
996
|
|
|
‡2
ISNI|0000000355877611
|
996
|
|
|
‡2
RERO|A005588428
|
996
|
|
|
‡2
NII|DA11455716
|
996
|
|
|
‡2
BIBSYS|12033479
|
996
|
|
|
‡2
LC|n 2008181476
|
996
|
|
|
‡2
RERO|A013122277
|
996
|
|
|
‡2
NUKAT|n 2017195782
|
996
|
|
|
‡2
NII|DA05891495
|
996
|
|
|
‡2
DNB|1041973020
|
996
|
|
|
‡2
BNF|14410536
|
996
|
|
|
‡2
ISNI|0000000373737452
|
996
|
|
|
‡2
DNB|1128655241
|
996
|
|
|
‡2
BIBSYS|1707374853124
|
996
|
|
|
‡2
LC|no2017009610
|
996
|
|
|
‡2
ISNI|0000000398118703
|
996
|
|
|
‡2
LC|n 93803040
|
996
|
|
|
‡2
DNB|1252527225
|
996
|
|
|
‡2
DNB|1237075858
|
996
|
|
|
‡2
DNB|1024362132
|
996
|
|
|
‡2
DNB|121484703X
|
996
|
|
|
‡2
NII|DA08179472
|
996
|
|
|
‡2
DNB|1038015928
|
996
|
|
|
‡2
LC|no2017102965
|
996
|
|
|
‡2
ISNI|0000000120651837
|
996
|
|
|
‡2
DNB|1102376000
|
996
|
|
|
‡2
DNB|1055528954
|
996
|
|
|
‡2
DNB|105864436X
|
996
|
|
|
‡2
DBC|87097919102572
|
996
|
|
|
‡2
DNB|1158516908
|
996
|
|
|
‡2
DBC|87097969381014
|
996
|
|
|
‡2
ISNI|0000000079965614
|
996
|
|
|
‡2
DNB|1013490827
|
996
|
|
|
‡2
ISNI|0000000498537040
|
996
|
|
|
‡2
SIMACOB|206347363
|
996
|
|
|
‡2
DNB|116105143
|
996
|
|
|
‡2
DNB|119048078
|
996
|
|
|
‡2
DNB|1294210890
|
996
|
|
|
‡2
LC|n 92032613
|
996
|
|
|
‡2
DNB|1227017456
|
996
|
|
|
‡2
ISNI|0000000028363410
|
996
|
|
|
‡2
BNF|15849395
|
996
|
|
|
‡2
DNB|1095113348
|
996
|
|
|
‡2
PTBNP|189285
|
996
|
|
|
‡2
DNB|123091076X
|
996
|
|
|
‡2
BIBSYS|98058517
|
996
|
|
|
‡2
DNB|134125592
|
996
|
|
|
‡2
LC|nb2019000909
|
996
|
|
|
‡2
CAOONL|ncf11733406
|
996
|
|
|
‡2
ISNI|0000000448894568
|
996
|
|
|
‡2
LC|n 2024183161
|
996
|
|
|
‡2
NTA|068006691
|
996
|
|
|
‡2
SUDOC|123013771
|
996
|
|
|
‡2
J9U|987011289060505171
|
996
|
|
|
‡2
DNB|103757473
|
996
|
|
|
‡2
NUKAT|n 2017050466
|
996
|
|
|
‡2
DNB|1147190577
|
996
|
|
|
‡2
LC|no2010203725
|
996
|
|
|
‡2
RERO|A009423074
|
996
|
|
|
‡2
NTA|420707158
|
996
|
|
|
‡2
SUDOC|119424533
|
996
|
|
|
‡2
DNB|1095113224
|
997
|
|
|
‡a
1960 0 lived 0000 0
‡9
1
|
998
|
|
|
‡a
Becker, Stephan
‡2
DNB|1206855991
‡3
exact title: (1.00, 'epitopesofnaturallyacquiredandvaccineinducedantiebolavirusglycoproteinantibodiesinsingleaminoacidresolution', 'epitopesofnaturallyacquiredandvaccineinducedantiebolavirusglycoproteinantibodiesinsingleaminoacidresolution')
‡3
suggested
|